| Autor: |
Resurreccion EP; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40506, USA., Fong KW; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40506, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
Metabolites [Metabolites] 2022 May 27; Vol. 12 (6). Date of Electronic Publication: 2022 May 27. |
| DOI: |
10.3390/metabo12060488 |
| Abstrakt: |
Our understanding of prostate cancer (PCa) has shifted from solely caused by a few genetic aberrations to a combination of complex biochemical dysregulations with the prostate metabolome at its core. The role of metabolomics in analyzing the pathophysiology of PCa is indispensable. However, to fully elucidate real-time complex dysregulation in prostate cells, an integrated approach based on metabolomics and other omics is warranted. Individually, genomics, transcriptomics, and proteomics are robust, but they are not enough to achieve a holistic view of PCa tumorigenesis. This review is the first of its kind to focus solely on the integration of metabolomics with multi-omic platforms in PCa research, including a detailed emphasis on the metabolomic profile of PCa. The authors intend to provide researchers in the field with a comprehensive knowledge base in PCa metabolomics and offer perspectives on overcoming limitations of the tool to guide future point-of-care applications. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
